Business ❯Pharmaceutical Industry

Drug Manufacturers

Novo Nordisk Pricing Strategies Merck AstraZeneca Price Negotiation Negotiation Strategies Price Negotiations Market Impact Market Regulations Legal Settlements Rebates PhRMA Distribution Companies Weight Loss Drugs Negotiation Process Purdue Pharma Market Trends Reformulation GSK Weight-loss Drugs Johnson & Johnson CEOs Bristol Myers Squibb Medication Pricing Medicare Part D Boehringer Ingelheim Novo Nordisk and Eli Lilly Eli Lilly GLP-1 Receptor Agonists Discount Programs Revenue Impact Price Negotiation Lawsuits Negotiation Processes Profitability Market Competition Market History Opioid Distributors

UK Reports 82 Deaths Potentially Linked to Popular Weight-Loss Drugs

Medicare Expands Drug Price Negotiations to Include Popular Weight-Loss Medications

Eli Lilly and Johnson & Johnson Challenge US Over 340B Drug Discount Program

Medicare Unveils New Rules for Drug Price Negotiations

Appeals Court Revives Challenge to US Drug Price Negotiation Law

FTC Sues Top Pharmacy Benefit Managers Over Inflated Insulin Prices

Bernie Sanders Pushes for Cheaper Ozempic Amid Medicare Price Negotiations

US Drug Prices Remain High Despite Medicare Negotiations

Biden and Harris Announce Major Medicare Drug Price Cuts

Jury Finds Zantac Not Responsible for Illinois Woman's Colon Cancer

EU Regulators Clear Ozempic and Related Drugs of Suicidal Thoughts Link

Boehringer Ingelheim Caps Inhaler Costs at $35 Amid Scrutiny

Federal Courts Dismiss Big Pharma Lawsuits Against Medicare Drug Price Negotiations

Federal Judge Dismisses AstraZeneca's Lawsuit Against Medicare Drug Price Negotiations

Pharma CEOs to Testify on High Drug Prices

Johnson & Johnson Settles with Washington State for $149.5M Over Opioid Crisis

Senate Committee to Subpoena Pharma CEOs Over Drug Pricing

FDA Seizes Thousands of Counterfeit Ozempic Units

WeightWatchers Launches Program for Weight Loss Drug Users